207 related articles for article (PubMed ID: 15717137)
1. Cardioprotective action of perindopril versus candesartan in renovascular hypertensive rats.
Nagai M; Horikoshi K; Izumi T; Seki S; Taniguchi M; Taniguchi I; Mochizuki S
Cardiovasc Drugs Ther; 2004 Sep; 18(5):353-62. PubMed ID: 15717137
[TBL] [Abstract][Full Text] [Related]
2. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
Paull JR; Widdop RE
J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
[TBL] [Abstract][Full Text] [Related]
3. Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin system.
Sebeková K; Lill M; Boor P; Heidland A; Amann K
Am J Nephrol; 2009; 29(3):164-70. PubMed ID: 18753741
[TBL] [Abstract][Full Text] [Related]
4. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
[TBL] [Abstract][Full Text] [Related]
5. "Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension.
Ishiguro K; Hayashi K; Sasamura H; Sakamaki Y; Itoh H
Hypertension; 2009 Jan; 53(1):83-9. PubMed ID: 19047581
[TBL] [Abstract][Full Text] [Related]
6. Telmisartan predominantly suppresses cardiac fibrosis, rather than hypertrophy, in renovascular hypertensive rats.
Kawai M; Hongo K; Komukai K; Morimoto S; Nagai M; Seki S; Taniguchi I; Mochizuki S; Yoshimura M
Hypertens Res; 2009 Jul; 32(7):604-10. PubMed ID: 19424279
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats.
Kim S; Zhan Y; Izumi Y; Iwao H
Hypertension; 2000 Mar; 35(3):769-74. PubMed ID: 10720593
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
O'Sullivan JB; Black MJ; Bertram JF; Bobik A
J Hypertens; 1994 Oct; 12(10):1163-70. PubMed ID: 7836732
[TBL] [Abstract][Full Text] [Related]
9. Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase.
Nakamura T; Tsutsumi Y; Shimizu Y; Uchiyama S
J Stroke Cerebrovasc Dis; 2010; 19(6):435-40. PubMed ID: 20702114
[TBL] [Abstract][Full Text] [Related]
10. Dual blockade of the renin-angiotensin system compared with a 50% increase in the dose of angiotensin-converting enzyme inhibitor: effects on proteinuria and blood pressure.
Kincaid-Smith P; Fairley KF; Packham D
Nephrol Dial Transplant; 2004 Sep; 19(9):2272-4. PubMed ID: 15252156
[TBL] [Abstract][Full Text] [Related]
11. [Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy].
Ovchinnikov AG; Serbul VM; Ageev FT
Ter Arkh; 2009; 81(5):64-71. PubMed ID: 19537590
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular status following combined angiotensin-converting enzyme and AT1 receptor inhibition in conscious spontaneously hypertensive rats.
Duke LM; Paull JR; Widdop RE
Clin Exp Pharmacol Physiol; 2003; 30(5-6):317-23. PubMed ID: 12859420
[TBL] [Abstract][Full Text] [Related]
13. Coronary microvasculature alteration in hypertensive rats. Effect of treatment with a diuretic and an ACE inhibitor.
Levy BI; Duriez M; Samuel JL
Am J Hypertens; 2001 Jan; 14(1):7-13. PubMed ID: 11206683
[TBL] [Abstract][Full Text] [Related]
14. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.
Brown L; Duce B; Miric G; Sernia C
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S143-8. PubMed ID: 9892155
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Sevikar® compared to the combination of perindopril plus amlodipine on central arterial blood pressure in patients with moderate-to-severe hypertension: Rationale and design of the SEVITENSION study.
Ruilope LM; Schaefer A
Contemp Clin Trials; 2011 Sep; 32(5):710-6. PubMed ID: 21586342
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of angiotensin II receptor blockade (candesartan) with angiotensin-converting enzyme inhibitor (quinapril) in rats with dilated cardiomyopathy.
Watanabe K; Juan W; Narasimman G; Ma M; Inoue M; Saito Y; Wahed MI; Nakazawa M; Hasegawa G; Naito M; Tachikawa H; Tanabe N; Kodama M; Aizawa Y; Yamamoto T; Yamaguchi K; Takahashi T
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S93-7. PubMed ID: 12693379
[TBL] [Abstract][Full Text] [Related]
17. Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome.
Fogari R; Zoppi A; Mugellini A; Maffioli P; Lazzari P; Derosa G
Hypertens Res; 2011 Dec; 34(12):1321-6. PubMed ID: 21814211
[TBL] [Abstract][Full Text] [Related]
18. Renal responses of the nonclipped kidney of two-kidney/one-clip Goldblatt hypertensive rats to type 1 angiotensin II receptor blockade with candesartan.
Cervenka L; Navar LG
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S197-201. PubMed ID: 9892163
[TBL] [Abstract][Full Text] [Related]
19. Candesartan ameliorates arsenic-induced hypertensive vascular remodeling by regularizing angiotensin II and TGF-beta signaling in rats.
Khuman MW; Harikumar SK; Sadam A; Kesavan M; Susanth VS; Parida S; Singh KP; Sarkar SN
Toxicology; 2016 Dec; 374():29-41. PubMed ID: 27889505
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus.
Derosa G; Cicero AF; Ciccarelli L; Fogari R
Clin Ther; 2003 Jul; 25(7):2006-21. PubMed ID: 12946547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
